GS
GS's valuation is somewhat elevated, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins.
GS vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 16x | 12x | 32% higher+32% |
| PE percentile | 74 | 50 | 49% higher+49% |
| EPS | $64.78 | $38.30 | 69% higher+69% |
| FCF | -$41.5B | -$10.3B | -$31.2B-$31.2B |
| Loading historical comparisons… | |||
GS’s earnings are above their historical averages, while its earnings multiple is higher.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Strong decline |
| Forward profitability | Strongly expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Moderate |
GS’s outlook is generally improving, with declining sales expectations a concern.
GS PE Valuation
This table applies GS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
GS Earnings Per Share
This chart tracks GS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
GS Quarterly Revenue
This chart tracks GS's quarterly revenue over time and shows how sales are changing from year to year.
GS Free Cash Flow
This chart tracks GS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
GS Total Shares
This chart tracks changes in GS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
GS Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
GS PE vs Financial Services Sector
This chart compares GS's price-to-earnings (PE) ratio with the Financial Services sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
GS Weekly Price
This chart uses GS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
GS Weekly Moving Averages
This chart compares GS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
GS Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
NMR
NMR's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins, though analyst coverage is limited.
NMR vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 13x | 11x | 20% higher+20% |
| PE percentile | 77 | 50 | 54% higher+54% |
| EPS | $0.86 | $0.48 | 79% higher+79% |
| FCF | $54.8M | -$4.4B | +$4.4B+$4.4B |
| Loading historical comparisons… | |||
NMR’s earnings are above their historical averages, while its earnings multiple is higher.
NMR Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly improving |
| Forward earnings | Strong growth |
| Forward revenue | Strong decline |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Tight |
NMR’s outlook is generally improving, with declining sales expectations a concern.
NMR PE Valuation
This table applies NMR's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
NMR Earnings Per Share
This chart tracks NMR's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
NMR Quarterly Revenue
This chart tracks NMR's quarterly revenue over time and shows how sales are changing from year to year.
NMR Free Cash Flow
This chart tracks NMR's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
NMR Total Shares
This chart tracks changes in NMR's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
NMR Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
NMR PE vs Financial Services Sector
This chart compares NMR's price-to-earnings (PE) ratio with the Financial Services sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
NMR Weekly Price
This chart uses NMR's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
NMR Weekly Moving Averages
This chart compares NMR's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
NMR Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.